Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BCAB will decline by -25.75% over the next 2 Weeks and hit $3.24 by Thursday, May 28, 2026. In that time frame, BCAB's share price is expected to range between $2.18 and $4.29.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 28, 2026 | 2.18 | 3.24 | 4.29 |
| May 27, 2026 | 2.48 | 3.58 | 4.66 |
| May 26, 2026 | 2.65 | 3.68 | 4.70 |
| May 25, 2026 | 3.00 | 3.97 | 5.03 |
| May 22, 2026 | 2.89 | 4.02 | 5.04 |
| May 21, 2026 | 2.63 | 3.73 | 4.82 |
| May 20, 2026 | 2.97 | 4.07 | 5.10 |
| May 19, 2026 | 3.11 | 4.17 | 5.24 |
| May 18, 2026 | 3.33 | 4.46 | 5.44 |
| May 15, 2026 | 3.38 | 4.51 | 5.63 |
BCAB shares fell -0.68% in Thursday, May 14, 2026's trading session, dropping from a previous close of $4.40 to move at $4.37. The stock demonstrated notable intraday movement (see BCAB's key stats for a full breakdown), fluctuating between $4.37 and $4.59, a +5.01% trading range. While recent weeks have seen some volatility, BCAB has managed to secure a +3.80% gain over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 9.71K shares changing hands, 1.89K fewer than the previous session. This amounted to $42.43K in total market activity.
Will BCAB Continue Its Downward Trend?
According to analyst ratings and projections for BCAB, BioAtla, Inc. shares are anticipated to decrease by -1.95%, potentially reaching $4.29 per share by May 28, 2026. Short-term technical indicators for BCAB currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 19 negative trading days within the past 30 sessions. Based on the BCAB stock forecast, now is not the best time to buy BCAB stock because its current trading price is +34.68% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on BCAB covering social and institutional perspectives.
BCAB Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BCAB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 39.52% to 42.40%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 41.01%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 44.11%, maintains a neutral outlook for the long term. Insights into BCAB's shareholder base show how institutional investors are positioning themselves during these momentum shifts
BioAtla Short-Term Forecasts
BCAB Forecast For Next 5 Days
Our algorithm anticipates BioAtla (BCAB) stock could hit $4.62 by May 22, 2026. This represents a +5.71% rise from today's price, following a +1.87% change over the past five days.
BCAB Forecast For Next 30 Days
Based on analysis of market trends, the outlook for BioAtla, Inc. (BCAB) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $3.74, which would mean a -14.42% decrease from the current price of $4.37. Projections for this period range from a high of $5.66 to a low of $1.40.
BCAB Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for BioAtla's price over the next three months point to a drop. BCAB stock is expected to peak at $8.16 on Jul 30, 2026 after potentially dipping to $0.00 on Jul 22, 2026. On average, BCAB is likely to trade around $2.45 in the coming 90 days.
BioAtla Stock Forecast 2025
Based on our predictive models, BioAtla (BCAB) is expected to trade between $0.00 and $8.16 throughout 2026. This would result in an average price of $4.56, potentially offering investors a +4.35% return from current levels.
BioAtla, Inc. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, BioAtla, Inc. (BCAB) is positioned to show a strong performance in May 2026. The price is predicted to move between $0.00 and $7.84, settling at an average of $3.89. This could translate to a -10.98% loss.
June 2026
Based on current market signals, BioAtla, Inc. is projected to trend june 2026. We forecast a trading range from $0.00 to $5.56, with a likely average price of $1.54. Investors could expect a potential return of -64.76%.
July 2026
Our predictive algorithms indicate BioAtla, Inc. stock may see a shift in July 2026. The expected range spans $0.00–$8.16, with an average target of $1.83. This represents a cautious outlook and a possible loss of -58.12%.
August 2026
Analyzing established trends, BioAtla, Inc. looks set to move in August 2026. Projections place the stock between $0.16 and $7.96, averaging around $4.19. This suggests a -4.12% loss from current levels.
September 2026
Market indicators suggest BioAtla, Inc. could experience notable changes during September 2026. Prices could fluctuate within $0.00 to $7.96, with a midpoint forecast of $5.07. The stock might deliver a +16.02% gain.
October 2026
Forecasting for October 2026, models estimate that BioAtla, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $7.07, averaging $7.46. This signals a positive trajectory with potential returns around +70.71%.
November 2026
According to our latest forecast models, BioAtla, Inc. (BCAB) is positioned to show a strong performance in November 2026. The price is predicted to move between $0.00 and $3.93, settling at an average of $7.34. This could translate to a +67.96% gain.
December 2026
Based on current market signals, BioAtla, Inc. is projected to trend december 2026. We forecast a trading range from $0.00 to $1.60, with a likely average price of $5.02. Investors could expect a potential return of +14.87%.
January 2027
Our predictive algorithms indicate BioAtla, Inc. stock may see a shift in January 2027. The expected range spans $0.00–$2.33, with an average target of $2.73. This represents a cautious outlook and a possible loss of -37.53%.
February 2027
Analyzing established trends, BioAtla, Inc. looks set to move in February 2027. Projections place the stock between $0.00 and $3.14, averaging around $1.17. This suggests a -73.23% loss from current levels.
March 2027
Market indicators suggest BioAtla, Inc. could experience notable changes during March 2027. Prices could fluctuate within $0.00 to $2.65, with a midpoint forecast of $0.92. The stock might deliver a -78.95% loss.
April 2027
Forecasting for April 2027, models estimate that BioAtla, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $3.67, averaging $0.43. This signals a cautious trajectory with potential returns around -90.16%.
May 2027
According to our latest forecast models, BioAtla, Inc. (BCAB) is positioned to show a strong performance in May 2027. The price is predicted to move between $0.00 and $3.02, settling at an average of $0.73. This could translate to a -83.30% loss.
BCAB's history of dividends and stock splits also plays a role in long-term investor confidence.